Search

Issue
Title
Authors
The role of matrix metalloproteinases in pathogenesis of renal disease
Bobkova I.N., Kozlovskaia L.V., Li O.A.
Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors
Karateev A.E., Nasonova V.A.
Features of the course of COVID-19 in patients with type 2 diabetes mellitus
Karaseva E.A., Martynov V.A., Filatova T.E., Maleev V.V., Grishin V.Y., Pronin N.S., Verbitskaya E.I., Popova V.I.
Efficacy of pharmacological inhibition of intestinal saccharases in patients with diabetes mellitus type 2 and/or visceral obesity
Ametov A.S., Kamynina L.L., Ametov A.S., Kamynina L.L.
Antiviral therapy of chronic hepatitis C: 30 years success story
Abdurakhmanov D.T., Rozina T.P., Nikulkina E.N., Burnevich E.Z., Tanashuk E.L., Severov M.V., Filatova A.L., Milovanova S.Y., Karpov V.V., Moiseev S.V.
Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022)
Aksenova A.V., Oschepkova E.V., Chazova I.E.
Janus kinase inhibitors in immunoinflammatory rheumatic diseases
Nasonov E.L.
Upper gastrointestinal bleeding in patients with stable coronary artery disease (registry of antithrombotic therapy “REGATТA” results)
Shakhmatova O.O., Komarov A.L., Korobkova V.V., Yarovaya E.B., Andreevskaya M.V., Shuleshova A.G., Panchenko E.P.
New directions of pharmacotherapy of immune - inflammatory rheumatic diseases
Nasonov E.L.
Modern achievements in the diagnosis and treatment of the refractory gastroesophageal reflux disease
Ivashkin V.T., Maev I.V., Trukhmanov A.S., Rumyantseva D.E.
Antiplatelet therapy with acetylsalicylic acid: Approaches to reducing the frequency of gastrointenstinal adverse reactions
Onuchina E.V.
Triple therapy for chronic hepatitis C: Practical Aspects
Bakulin I.G., Kiseleva A.V.
Cough: Differential diagnosis and differentiated treatment
Sinopal'nikov A.I., Kliachkina I.L.
Essential hypertension, dementia, and antihypertensive therapy in geriatric patients
Kobalava Z.D., Kotovskaya Y.V., Tyul'kina E.E., Kobalava Z.D., Kotovskaya Y.V., Tyulkina E.E.
Effects of different treatments on endothelial function in patients with erectile dysfunction and hypogonadism
Mazo E.B., Gamidov S.I., Sotnikova E.M., Mazo E.B., Gamidov S.I., Sotnikova E.M.
Endothelium a new target for a therapeutic action of ACE inhibitors
Karpov Y.A.
Pharmacogenetics of dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes mellitus: A review
Samoilova I.G., Vaizova O.E., Stankova A.E., Matveeva M.V., Podchinenova D.V., Kudlay D.A., Borozinets A.A., Filippova T.A., Grishkevich I.R., Partala A.V., Gerasimova D.A.
SGLT2 inhibitors in acute decompensated heart failure, what do we know?
Lapteva A.E., Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
COVID-19 and cardiovascular diseases
Chazova I.E., Mironova O.I.
Rheumatoid arthritis: achievements and unresolved issues
Nasonov E.L., Lila A.M.
Schnitzler syndrome: A review of literature, the authors’ observation, and experience with the interleukin-1 inhibitor canakinumab
Salugina S.O., Gorodetsky V.R., Fedorov E.S., Lopatina N.E., Evsikova M.D.
Efficacy of a fixed-dose combination of perindopril and amlodipine in the treatment of hypertensive patients. A clinical case
Poteshkina N.G., Khashieva F.M.
Angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase-4
Oskola E.V., Shubina A.T., Karpov I.A.
PHARMACOLOGICAL NEPHROPROTECTION IN CHRONIC KIDNEY DISEASE: CURRENT OPPORTUNITIES AND PERSPECTIVES (REVIEW OF FOREIGN LITERATURE)
Nikolaev A.Y.
Clinical implications of urine matrix metalloproteinases assay in patients with chronic glomerulonephritis
Li O.A., Bobkova I.N., Kozlovskaya L.V., Lee O.A., Bobkova I.N., Kozlovskaya L.V.
Impact of long-term antihypertensive therapy on the vasoregulating function of the brachial artery in patients with arterialhypertension associated with type 2 diabetes mellitus
Karpov R.S., Koshelskaya O.A., Falkovskaya A.Y., Ocheredko N.A., Atroshenkov A.V., Makarova Y.V.
Reduction in the need for glucocorticoids on the background of therapy with biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis: evidence from real clinical practice
Potapova A.S., Karateev A.E., Polishchuk E.Y., Filatova E.S., Amirdzhanova V.N., Lila A.M.
Tactics of antihypertensive therapy during COVID-19 pandemic
Podzolkov V.I., Bragina A.Е., Rodionova Y.N., Bragina G.I., Bykova E.E.
Successful use of long-term follow-up in patients with chronic myeloid leukemia with a deep molecular response at reduced doses of 2nd generation tyrosine kinase inhibitors: clinical cases and literature review
Gurianova M.A., Chelysheva E.Y., Shukhov O.A., Turkina A.G.
Chronic gout: causes, clinical manifestations, treatment
Barskova V.G., Barskova V.G.
Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy
Maev I.V., Andreev D.N.
The problem of viral hepatitis C in the Russian Federation
Iushchuk N.D., Znoĭko O.O., Dudina K.R., Belyĭ P.A.
What is the optimal choice of antihypertensive therapy based on: the class-specific effects or special properties of a drug?
Adasheva T.V., Samorukova E.I., Zadionchenko V.S., Nesterenko O.I.
CURRENT ANTI-INFLAMMATORY TREATMENT IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Shmelev E.I., Shmeleva N.M.
Renin as a target of direct pharmacological block in arterial hypertension
Mukhin N.A., Fomin V.V., Mukhin N.A., Fomin V.V.
Clinical and hemodynamic efficacy ofprestarium and its role in the treatment of chronic pulmonary heart
Korneichuk N.N., Butorov I.V., Verbitsky O.N., Butorova V.G., Paraska V.I.
Long-term uroseptic and metabolic effects of a herbal medicinal preparation in women with type 2 diabetes taken gliflosins
Tsygankova O.V., Timoshchenko O.V., Apartseva N.E., Latyntseva L.D.
Kidney injury associated with antitumor therapy: focus on the adverse events of modern immuno-oncological drugs
Kamyshova E.S., Bobkova I.N., Sekacheva M.I.
Modern view on treatment of membranous nephropathy
Bobkova I.N., Kamyshova E.S.
Proton pump inhibitors receiving and prognosis of patients after scheduled percutaneous coronary interventions
Komarov A.L., Shakhmatova O.O., Muraseeva V., Novikova E.S., Guskova E.V., Panchenko E.P.
Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice
Andreev D.N., Dicheva D.T., Maev I.V.
Principles of choice of an angiotensin-converting enzyme inhibitor: Specific features of perindopril
Morozova T.E., Gontarenko S.V., Kuz'mina E.R.
Experience with Invirase as part of triple therapy as the drug of choice in the perinatal prevention of HIV transmission in the Ulyanovsk Region
Salminskaia O.I.
Role of matrix metalloproteinase-9 in the pathogenesis of osteoporosis in patients with chronic obstructive pulmonary disease
Kochetkova E.A., Ugaĭ L.G., Maĭstrovskaia I.V., Buria K.A., Nevzorova V.A.
Significance of matrix metalloproteinases and their ihhibitors in normal subjects, solid and blood cancer patients
Gaydamaka N.V., Parovichnikova E.N., Zavalishina L.E., Savchenko V.G., Frank G.A., Gaidamaka N.V., Parovichnikova E.N., Zavalishina L.E., Savchenko V.G., Frank G.A.
Influence of long-term intake of proton pump inhibitors on gastric mucosa and neuroendocrine system of gastric secretion regulation in patients with acid-dependent diseases
Rapoport S.I., Khutsishvili M.B., Rasulov M.I., Trubitsina I.E., Raĭkhlin I.T.
Interaction of nonsteroid antiinflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)
Tsurko V.V., Preobrazhensky D.V., Obukhova О.A.
Pharmacotherapy for acute respiratory infections caused by influenza viruses: current possibilities
Zyryanov S.K., Butranova O.I., Gaidai D.S., Kryshen K.L.
Survival of bDMARDs in bionaive patients with rheumatoid arthritis: data from a retrospective 12-month follow-up
Aronova E.S., Lukina G.V., Glukhova S.I., Gridneva G.I., Kudryavtseva A.V.
The use of Tofacitinib in the treatment of inflammatory bowel disease
Nasonov E.L., Abdulganieva D.I., Fairushina I.F.
Possibilities of pH impedance and high-resolution manometry in managing patients with refractory gastroesophageal reflux disease
Maev I.V., Barkalova E.V., Ovsepyan M.A., Kucheryavyi Y.A., Andreev D.N.
Effect of dipeptidyl peptidase-4 inhibitors on fat metabolism in patients with type 2 diabetes mellitus
Ametov A.S., Gusenbekova D.G.
Pharmacotherapy for rheumatoid arthritis in the early 21st century: Russian and international experience
Nasonov E.L., Karateev D.E., Lukina G.V.
Diagnosis and treatment of gastroesophageal reflux disease
Trukhmanov A.S., Trukhmanov A.S.
Prophylaxis of cardiovascular diseases in rheumatoid arthritis
Novikova D.S., Popkova T.V., Nasonov E.L., Novikova D.S., Popkova T.V., Nasonov E.L.
ACE inhibitors in the treatment of ischemicheart disease and prevention of its complications (review)
Schekotov V.V.
Change in the activity of angiotensin-converting enzyme in pneumonia and chronic obstructive lung diseases
Altshuler B.Y., Roitman A.P., Fedorova T.A., Novazhenov V.G., Belkov S.A., Gordeev M.N., Yarovaya G.A., Neshkova Y.A., Ustinov A.A.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E.L., Vaizova O.E., Meleshko M.V., Samoilova I.G., Podchinenova D.V., Borozinets A.A., Matveeva M.V., Kudlay D.A.
Effect of physicochemical properties on the pharmacokinetic parameters of the new representative of benzothiazinones antituberculosis drug macozinonе
Khokhlov A.L., Mariandyshev A.O., Shcherbakova V.S., Ozerova I.V., Kazaishvili Y.G., Igumnova O.V., Bolgarina A.A., Rudoy B.A.
The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)
Mariandyshev A.O., Khokhlov A.L., Smerdin S.V., Shcherbakova V.S., Igumnova O.V., Ozerova I.V., Bolgarina A.A., Nikitina N.A.
Problems of nociception in gastroesophageal reflux disease: diagnostics and treatment of irritated oesophagus
Sablin O.A., Ilchishina T.A.
Resistance to protease inhibitors and efficiency of antiviral therapy in patients with chronic hepatitis C
Batskikh S.N., Karandashova I.V., Neverov A.D., Chulanov V.P.
Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases
Samsonov A.A., Grechushnikov V.B., Andreev D.N., Iurenev G.L., Korovina T.I., Lezhneva I.A., Maev I.V.
Therapeutic strategy for chronic myeloid leukemia: possibilities and prospects
Turkina A.G., Chelysheva E.I.
Fozinopril in the treatment of cardiorenal syndrome in chronic cardiac failure
Tereshchenko S.N., Zhirov I.V., Tereschenko S.N., Zhirov I.V.
How to diagnose functional (non-ulcerative) dyspepsia (a review)
Маеу I.V., Vyuchnova Y.S., Lebedeva Y.G., Yakimova S.S.
ACE inhibitor quinapril in the treatment of chronic cardiac failure
Gadzhiev A.N.
Rebamipide: thirty years of experience. A review
Bakulina N.V., Ponomarenko V.A., Bakulin I.G.
The effect of a medicinal plant preparation on the frequency of episodes of exacerbation of recurrent cystitis and metabolic parameters in patients with type 2 diabetes mellitus taking glyphlosins
Tsygankova O.V., Evdokimova N.E., Timoshchenko O.V., Latyntseva L.D.
Modern approaches to conservative therapy of polycystic kidney disease
Rudenko T.E., Bobkova I.N., Stavrovskaya E.V.
Diagnostics and treatment challenges of Ph-like acute lymphoblastic leukemia: a description of 3 clinical cases
ZARUBINA K.I., PAROVICHNIKOVA E.N., BASKHAEVA G.A., KRASILNIKOVA A.E., GAVRILINA O.A., BIDERMAN B.V., SUDARIKOV A.B., BONDARENKO S.N., DAVYDOVA Y.O., GALTSEVA I.V., SOKOLOV A.N., TROITSKAYA V.V., SAVCHENKO V.G.
Adherence with proton pump inhibitor therapy, by continuously taking nonsteroidal anti-inflammatory drugs
Pimanov S.I., Makarenko E.V., Dikareva E.A.
Eradication therapy for Helicobacter pylori infection: Review of world trends
Maev I.V., Kucheriavyĭ I.A., Andreev D.N., Barkalova E.V.
Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
Ametov A.S., Kamynina L.L.
Optimization of the control of blood pressure. What contribution can be obtained from use of combinations of fixed doses of ACE inhibitors and calcium channel blockers?
Eliseev O.M., Eliseev O.M.
Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase
Vinogradova O.Y., Turkina A.G., Vorontsova A.V., Chelysheva E.Y., Gusarova G.A., Kuznetsov S.V., Goryacheva S.R., Sokolova M.A., Abakumov E.M., Stakhina O.V., Domracheva E.V., Misyurin A.V., Khoroshko N.D., Vinogradova O.Y., Turkina A.G., Vorontsova A.V., Chelysheva E.Y., Gusarova G.A., Kuznetsov S.V., Goryacheva S.R., Sokolova M.A., Abakumov E.M., Stakhina O.V., Domracheva E.V., Misyurin A.V., Khoroshko N.D.
Erectile dysfunction in patients withischemic heart disease (review)
Gamidov S.I., Mazo E.В., Ovchinnikov R.I., Kurochkin E.E., Iremashvili V.V.
Long-term goflkicept therapy for patients with idiopathic recurrent pericarditis: results of the interim analysis of an ongoing open-label extension study
Myachikova V.Y., Maslyanskiy A.L., Moiseeva O.M., Schedrova M.L., Egorova A.N., Ponomar Е.G., Samsonov M.Y.
Efficacy and safety of the use of alirocumab in real clinical practice
Korneva V.A., Kuznetsova T.Y., Scopets I.S., Vezikova N.N.
Urinary tract infections in patients with type 2 diabetes mellitus with pharmacological glucosuria
Sturov N.V., Popov S.V., Mamporia N.K., Mager A.A.
The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications
Ostroumova O.D., Kochetkov A.I., Pereverzev A.P., Kravchenko E.V., Kazjulin A.N., Andreev D.N., Pavleeva E.E.
NSAID-induced enteropathy: the current state of the problem
Svistunov A.A., Osadchuk M.A., Kireeva N.V., Hudarova A.A., Achkasov E.E.
Inadequate response to proton pump inhibitor therapy: Causes and patient management tactics
Evsiutina I.V., Trukhmanov A.S.
Hypoglycemia in patients with type 2 diabetes mellitus: Safe solution of the dangerous problem
Shestakova M.V., Khalimov I.S.
Blood pressure variability and risk for complications in arterial hypertension
Ostroumova O.D.
Influence of regular use of vardenafil on endothelial and erectile functions in patients with arteriogenic erectile dysfunction
Gamidov S.I., Shcherbakov D.V., Tkhagapsoeva R.A., Koroteev R.V., Gamidov S.I., Shcherbakov D.V., Tkhagapsoyeva R.A., Koroteyev R.V.
Trisomy of chromosome 8 in Ph-negative cells of the bone marrow in patients with chronic myeloid leukemia treated with inhibitors of BCR-ABL tyrosinkinases
Turkina A.G., Domracheva E.V., Vorontsova A.V., Aseeva E.A., Vinogradova O.Y., Stakhina O.V., Gusarova G.A., Dyagileva O.A., Semenova E.A., Vakhrusheva M.V., Kolosheynova T.I., Abakumov E.M., Chelysheva E.Y., Goryacheva S.R., Ivanova T.V., Zakharova E.S., Kolosova L.Y., Zakharova A.V., Naumova I.N., Dyachenko L.V., Kulikov S.M., Kovaleva L.G., Khoroshko N.D., Turkina A.G., Domracheva E.V., Vorontsova A.V., Aseeva E.A., Vinogradova O.Y., Stakhina O.V., Gusarova G.A., Dyagileva O.A., Semenova E.A., Vakhrusheva M.V., Kolosheinova T.I., Abakumov E.M., Chelysheva E.Y., Goryacheva S.R., Ivanova T.V., Zakharova E.S., Kolosova L.Y., Zakharova A.V., Naumova I.N., Dyachenko L.V., Kulikov S.M., Kovaleva L.G., Khoroshko N.D.
Progressiveazotemia provoked by ACE inhibitor in renal ischemia
Fomin V.V., Taronishvili О.I., Shvetsov M.Y., Shilov E.M., Moiseev S.V., Kushnir V.V., Sorokin Y.D.
1 - 88 of 88 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».